Kuros Biosciences, a Swiss-based orthobiologics firm reported $141.8 million of product sales, up 40% from $101.1 million a year earlier for the nine months ended September 2026.
Company News Premium
Kuros Reports 40% YOY Sales Growth
1 min read Premium comments

Kuros Biosciences#magnetos2026 sales3Q26 financial results
Author
React:
